Rossari Biotech Ltd
NSE:ROSSARI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (3.2), the stock would be worth ₹981.86 (105% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.6 | ₹478.95 |
0%
|
| 3-Year Average | 3.2 | ₹981.86 |
+105%
|
| 5-Year Average | 3.7 | ₹1 119.37 |
+134%
|
| Industry Average | 2.2 | ₹682.17 |
+42%
|
| Country Average | 2.3 | ₹687.79 |
+44%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Rossari Biotech Ltd
NSE:ROSSARI
|
26.5B INR | 1.6 | 19.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13.2T JPY | 3.1 | 27.8 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
78.8B USD | 3.8 | 30.7 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
73.2B USD | 3.6 | 35.3 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.6 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
280.3B CNY | 1.6 | 21.3 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
25.7B CHF | 2.9 | 24 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 6.6 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR | 10.8 | 60.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24B USD | 1.8 | 15.2 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.6 | 17.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.3 |
| Median | 2.3 |
| 70th Percentile | 4.2 |
| Max | 4 185.7 |
Other Multiples
Rossari Biotech Ltd
Glance View
Rossari Biotech Ltd. operates as a specialty chemicals manufacturing company. The company is headquartered in Mumbai, Maharashtra and currently employs 451 full-time employees. The company went IPO on 2020-07-23. The firm provides customized solutions to industrial and production requirements of its customers through its diversified product portfolio. The company builds its expertise from textiles and has diversified into the animal health and nutrition, home, personal care and performance chemicals markets. The company offers a range of sustainable products for pre-treatment, dyeing, printing, finishing processes, and specialty chemicals. The firm provides specialty chemical solutions across the entire value-chain of the textile industry starting from thread, yarn and man-made fiber production to digital printing, fabric processing, dyeing auxiliaries and garment finishing range. The company develops product portfolio for its businesses of home, personal care and performance chemicals. The firm operates two manufacturing facilities at Silvassa and Dahej.
